Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.43 |
| ▸ | GSR | P00390 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fotemustine SCHEMBL8880 | 0.99 | ALDH1A1 (0.44) | ALDH1A1BLMPMP22MEN1ABCB11 | |
| Fotemustine SCHEMBL8881 | 0.99 | ALDH1A1 (0.44) | ALDH1A1BLMPMP22MEN1ABCB11 | |
| Fotemustine SCHEMBL16174560 | 0.99 | ALDH1A1 (0.44) | ALDH1A1BLMPMP22MEN1ABCB11 | |
| Fotemustine SCHEMBL3982212 | 0.96 | ALDH1A1 (0.42) | ALDH1A1BLMPMP22MEN1ABCB11 | |
| Fotemustine SCHEMBL14697056 | 0.89 | ALDH1A1 (0.36) | ALDH1A1BLMPMP22MEN1ABCB11 | |
| SCHEMBL25859933 | 0.88 | GAA (0.36) | ALDH1A1BLMPMP22MEN1ABCB11 | |
| SCHEMBL17524418 | 0.88 | GAA (0.36) | ALDH1A1BLMPMP22MEN1ABCB11 | |
| Fotemustine SCHEMBL4448327 | 0.87 | ADRA2A (0.62) | ALDH1A1BLMPMP22MEN1ABCB11 | |
| SCHEMBL10893811 | 0.86 | ALDH1A1 (0.42) | ALDH1A1BLMPMP22MEN1ABCB11 | |
| SCHEMBL25860601 | 0.85 | GAA (0.35) | SMN1; SMN2GAACYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110325533-A | INHIBITORS OF THE MENIN-MLL INTERACTION | 生命医药有限责任公司 | 2019-10-11 | — | — | CN | disclosed |
| CN-109970708-A | Cannibinoid receptor modulators | 艾尼纳制药公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-109640985-A | The combination treatment of hdac inhibitor and PD-L1 inhibitor | 沪亚生物国际有限责任公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-103492369-B | Cannabinoid receptor modulators | 艾尼纳制药公司 | 2019-03-29 | — | — | CN | disclosed |
| CN-108135904-A | For treating the combination of the BTK inhibitor of Huppert's disease | 药品循环有限责任公司 | 2018-06-08 | — | — | CN | disclosed |
| CN-106999471-A | Cancer diagnosis and treatment | 吉列斯莫钦杜研究所 | 2017-08-01 | — | — | CN | disclosed |
| CN-107002043-A | The survivin specific t-cell receptor of target tumor and non-T cell | 贝勒医学院 | 2017-08-01 | — | — | CN | disclosed |
| CN-106551934-A | A kind of pharmaceutical composition and its application | 康朴生物医药技术（上海）有限公司 | 2017-04-05 | — | — | CN | disclosed |
| CN-102612367-A | Prolyl hydroxylase inhibitors | AKEBIA THERAPEUTICS INC | 2012-07-25 | — | — | CN | disclosed |
| CN-102595896-A | Method for improving stability of hypoxia inducible factor-1 alpha | AKEBIA THERAPEUTICS INC | 2012-07-18 | — | — | CN | disclosed |
| CN-102438452-A | Compounds and compositions comprising cdk inhibitors and methods for the treatment of cancer | UNIV GEORGIA STATE RES FOUND | 2012-05-02 | — | — | CN | disclosed |
| WO-2003005965-A2 | MODULATORS OF CERAMIDASE AND METHODS OF USE BASED THEREON | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) | 2003-01-23 | — | — | WO | disclosed |